S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
Log in

NASDAQ:PRAH - PRA Health Sciences Stock Price, Forecast & News

$103.27
-2.04 (-1.94 %)
(As of 01/27/2020 04:00 PM ET)
Today's Range
$102.98
Now: $103.27
$104.96
50-Day Range
$101.58
MA: $107.23
$111.15
52-Week Range
$85.00
Now: $103.27
$115.50
Volume265,145 shs
Average Volume565,609 shs
Market Capitalization$6.53 billion
P/E Ratio28.69
Dividend YieldN/A
Beta1.14
PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. Read More…

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRAH
CUSIPN/A
Phone919-786-8200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.87 billion
Cash Flow$5.77 per share
Book Value$16.18 per share

Profitability

Net Income$153.90 million

Miscellaneous

Employees16,400
Market Cap$6.53 billion
Next Earnings Date2/26/2020 (Estimated)
OptionableOptionable

Receive PRAH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRAH and its competitors with MarketBeat's FREE daily newsletter.


PRA Health Sciences (NASDAQ:PRAH) Frequently Asked Questions

What is PRA Health Sciences' stock symbol?

PRA Health Sciences trades on the NASDAQ under the ticker symbol "PRAH."

How were PRA Health Sciences' earnings last quarter?

PRA Health Sciences Inc (NASDAQ:PRAH) announced its quarterly earnings results on Wednesday, October, 30th. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.29 by $0.03. The medical research company earned $780.70 million during the quarter, compared to the consensus estimate of $771.64 million. PRA Health Sciences had a return on equity of 27.73% and a net margin of 8.00%. The firm's quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.13 EPS. View PRA Health Sciences' Earnings History.

When is PRA Health Sciences' next earnings date?

PRA Health Sciences is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for PRA Health Sciences.

What guidance has PRA Health Sciences issued on next quarter's earnings?

PRA Health Sciences updated its FY19 earnings guidance on Wednesday, October, 30th. The company provided EPS guidance of $5.07-$5.12 for the period, compared to the Thomson Reuters consensus estimate of $5.07. The company issued revenue guidance of $3.02-$3.10 billion, compared to the consensus revenue estimate of $3.06 billion.

What price target have analysts set for PRAH?

10 equities research analysts have issued twelve-month price targets for PRA Health Sciences' shares. Their forecasts range from $100.00 to $123.00. On average, they anticipate PRA Health Sciences' share price to reach $116.44 in the next year. This suggests a possible upside of 12.8% from the stock's current price. View Analyst Price Targets for PRA Health Sciences.

What is the consensus analysts' recommendation for PRA Health Sciences?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PRA Health Sciences in the last year. There are currently 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for PRA Health Sciences.

Has PRA Health Sciences been receiving favorable news coverage?

Media stories about PRAH stock have been trending somewhat negative recently, InfoTrie reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. PRA Health Sciences earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned headlines about the medical research company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for PRA Health Sciences.

Are investors shorting PRA Health Sciences?

PRA Health Sciences saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 2,090,000 shares, an increase of 29.8% from the December 31st total of 1,610,000 shares. Based on an average trading volume of 501,500 shares, the short-interest ratio is presently 4.2 days. Approximately 3.3% of the shares of the company are short sold. View PRA Health Sciences' Current Options Chain.

Who are some of PRA Health Sciences' key competitors?

What other stocks do shareholders of PRA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PRA Health Sciences investors own include NVIDIA (NVDA), Alibaba Group (BABA), Adobe (ADBE), Paypal (PYPL), Applied Materials (AMAT), Veeva Systems (VEEV), Lam Research (LRCX), Netflix (NFLX), Arista Networks (ANET) and Walt Disney (DIS).

Who are PRA Health Sciences' key executives?

PRA Health Sciences' management team includes the folowing people:
  • Mr. Colin Shannon, Chairman, CEO & Pres (Age 60)
  • Mr. Michael J. Bonello, Exec. VP, CFO & Corp. Sec. (Age 49)
  • Mr. Kent Thoelke, Exec. VP & Chief Scientific Officer
  • Mr. Thomas Byrne, VP of Legal Affairs
  • Christine Rogers, Director of PR & Corp. Communications

When did PRA Health Sciences IPO?

(PRAH) raised $306 million in an initial public offering on Thursday, November 13th 2014. The company issued 17,000,000 shares at $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers.

Who are PRA Health Sciences' major shareholders?

PRA Health Sciences' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Strs Ohio (0.29%), Virginia Retirement Systems ET AL (0.28%), Reilly Financial Advisors LLC (0.18%), Assenagon Asset Management S.A. (0.16%), Artemis Investment Management LLP (0.15%) and Scout Investments Inc. (0.15%). Company insiders that own PRA Health Sciences stock include Fund Holdings LP Kkr and Pra Investors LP Kkr. View Institutional Ownership Trends for PRA Health Sciences.

Which institutional investors are selling PRA Health Sciences stock?

PRAH stock was sold by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, Strs Ohio, Gateway Investment Advisers LLC, Sciencast Management LP, Arizona State Retirement System, Scout Investments Inc., Nisa Investment Advisors LLC and State of Alaska Department of Revenue. View Insider Buying and Selling for PRA Health Sciences.

Which institutional investors are buying PRA Health Sciences stock?

PRAH stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Three Peaks Capital Management LLC, Reilly Financial Advisors LLC, Campbell & CO Investment Adviser LLC, Fulton Breakefield Broenniman LLC, New York State Teachers Retirement System, FNY Investment Advisers LLC and Advisors Capital Management LLC. View Insider Buying and Selling for PRA Health Sciences.

How do I buy shares of PRA Health Sciences?

Shares of PRAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is PRA Health Sciences' stock price today?

One share of PRAH stock can currently be purchased for approximately $103.27.

How big of a company is PRA Health Sciences?

PRA Health Sciences has a market capitalization of $6.53 billion and generates $2.87 billion in revenue each year. The medical research company earns $153.90 million in net income (profit) each year or $3.93 on an earnings per share basis. PRA Health Sciences employs 16,400 workers across the globe.View Additional Information About PRA Health Sciences.

What is PRA Health Sciences' official website?

The official website for PRA Health Sciences is http://www.prahs.com/.

How can I contact PRA Health Sciences?

PRA Health Sciences' mailing address is 4130 PARKLAKE AVENUE SUITE 400, RALEIGH NC, 27612. The medical research company can be reached via phone at 919-786-8200 or via email at [email protected]


MarketBeat Community Rating for PRA Health Sciences (NASDAQ PRAH)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  343 (Vote Outperform)
Underperform Votes:  311 (Vote Underperform)
Total Votes:  654
MarketBeat's community ratings are surveys of what our community members think about PRA Health Sciences and other stocks. Vote "Outperform" if you believe PRAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRAH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: Overbought

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel